Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Inhalation Sciences Sweden

0,31 SEK

+4,67 %

Mindre end 1K følgere

ISAB

Spotlight Stock Market

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
+4,67 %
-29,91 %
-39,03 %
-37,20 %
-80,37 %
-80,20 %
-93,59 %
-96,97 %
-96,20 %

Inhalation Sciences Sweden, ISAB, is a research company. The company focuses primarily on the production and development of laboratory instruments. The instruments are used to measure particles in inhaled air and how the composition of the air affects the lungs. The company sells products under various brands, mainly on the European market. Inhalation Sciences Sweden was founded in 2004 and is headquartered in Huddinge.

Læs mere
Markedsværdi
12,3 mio. SEK
Aktieomsætning
318,1 t SEK
Omsætning
11,05 mio.
EBIT %
-45,97 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
27.2
2026

Årsrapport '25

11.5
2026

Delårsrapport Q1'26

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelsefor 18 timer siden

Inhalation Sciences receives purchase order worth 160 KEUR from international distributor for the US market

Inhalation Sciences Sweden
Selskabsmeddelelse4.11.2025, 07.30

Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations

Inhalation Sciences Sweden
Selskabsmeddelelse24.10.2025, 06.30

Inhalation Sciences receives IRS order from leading European university hospital

Inhalation Sciences Sweden

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Pressemeddelelse7.10.2025, 07.00

Inhalation Sciences to Present abstracts from the FDA-Funded Evaluation Study on DissolvIt® and the APRINHA Project at the 2025 DDL Conference

Inhalation Sciences Sweden
Pressemeddelelse2.10.2025, 06.30

Inhalation Sciences receives service orders from recurring global pharma customers

Inhalation Sciences Sweden
Pressemeddelelse19.9.2025, 06.30

Inhalation Sciences: University of Liège highlights the value of PreciseInhale® in advancing Inhalation Research

Inhalation Sciences Sweden
Pressemeddelelse17.9.2025, 11.45

Inhalation Sciences launches marketing campaign to increase awareness

Inhalation Sciences Sweden
Pressemeddelelse1.7.2025, 08.00

Inhalation Sciences receives service order from recurring global pharmaceutical customer

Inhalation Sciences Sweden
Selskabsmeddelelse27.5.2025, 12.00

Inhalation Sciences AB (publ) releases Annual Report 2024

Inhalation Sciences Sweden
Pressemeddelelse27.5.2025, 06.00

Inhalation Sciences appoints Ulf Wedenberg as Chief Commercial Officer (CCO)

Inhalation Sciences Sweden
Pressemeddelelse22.5.2025, 06.30

Inhalation Sciences Signs Strategic Agreement with U.S.-based BioLum Sciences, expanding U.S. Presence & Commercial Reach to Advance In Vitro Respiratory Research

Inhalation Sciences Sweden
Pressemeddelelse8.5.2025, 06.30

Inhalation Sciences receives new IRS orders from returning customers - increased demand in line with regulatory requirements

Inhalation Sciences Sweden
Selskabsmeddelelse24.4.2025, 06.00

Inhalation Sciences AB reports positive primary and secondary study results in the FDA-funded study of DissolvIt® and receives approval from the FDA to publish the study results

Inhalation Sciences Sweden
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.